Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by general360on Jun 10, 2020 11:32am
263 Views
Post# 31133526

so here we r.....

so here we r.....
yep, exactly, amongst the more carrots...

"registration trial"
"expensive phase 3"
"partner" vs "partnerS"?
waiting FDA written feedback

tried to re-listen to that part but will have to wait for the recording to be posted...

still going to be funded internally until.....

"will be glad to share once written confirmation from the FDA received"....

distinctly heard "registration trial", which to me means P4?  then he went on and said "expensive P3 which partner will be paying for"...

if i wasnt so fatigued, id be.....MEH.... u know, kinda like the market...

BUT, thank u for directly addressing the 800LB gorilla....HEDGIE dumping a big position?  that would be hundreds of thousands if not over a 1m shares in past week or so?  it's a "Failed NY hedgie", i wonder how many funds are failing right now with the NAS at all time highs, the DOW only a few % below peak, and SP is right there too, cant be that hard to find out how many hedgies have failed in the last couple weeks say...  he did say we should rebound to where we were a year ago....not clear if that's back to the 2-3-4$ we were at around last june... but then again, these were the ppl apparently saying they thot we'd hit 5$ w/ BTD....

and i wanted more deets on the COVID funding...NIH grant for HIV?

anyways...MEH.... the wait continues....i'm inserting a thot here: it cant be that long to hear back from the FDA, maybe just a couple more weeks if we were just turning around and making requested changes.....

.
Bullboard Posts